PolyPid Employee Directory

PolyPid corporate office is located in 18 Hasivim St, Petah Tiqwa, Central District, 4917002, Israel and has 51-200 employees.

Likely to Engage tag.Highly Engaged Employees

Employees by Department

Departments

Number of employees

Engineering & Technical

12

Medical & Health

11

Operations

10

Legal

6

C-Suite

6

Finance

4

Information Technology

1

PolyPid CEO

DA
Israel flag for contact location.
Dikla AkselbradChief Executive Officer & Board Member
Flame icon indicating likelihood to engage via phone.PhonePhoneFlame icon indicating likelihood to engage via email.EmailEmail
See Profile

Key Employees of PolyPid

PolyPid Global Presence

globalPresence illustration
Asia51-200

Index of contact profiles from PolyPid

Hundreds of professionals searching for PolyPid have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
123

Former Employees at PolyPid

Explore people who held key positions, contributed to PolyPid's success, and advanced their careers.

People from Similar Companies in the Manufacturing Industry Located in Israel

Frequently Asked Questions Regarding PolyPid Employees

How many employees does PolyPid have?
PolyPid has 51-200 employees
Who is the CEO of PolyPid?
PolyPid’s CEO is Dikla Akselbrad
Who is the CFO of PolyPid?
PolyPid’s CFO is Shaun Marcus
Who are PolyPid key employees?
Some of PolyPid key employees are Johnny Missulawin, Shaun Marcus, Nurit Tweezer-Zaks
Where is PolyPid located?
PolyPid’s headquarters are located at 18 Hasivim St, Petah Tiqwa, Central District, 4917002, Israel
How do I contact PolyPid?
PolyPid Contact Info: Phone number: +972 747195700 Website: www.polypid.com
What does PolyPid do?

PolyPid Ltd. (Nasdaq: PYPD) is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, PolyPid's proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with Active Pharmaceutical Ingredients (APIs), enabling precise delivery of drugs at optimal rel... ease rates over durations ranging from several days to months. PolyPid's lead product candidate D-PLEX100 is in Phase 3 clinical trials for the prevention of soft tissue abdominal and sternal bone surgical site infections. In addition, the Company is currently in preclinical stages to test the efficacy of OncoPLEX for treatment of solid tumors, beginning with glioblastoma.Read More

Is PolyPid a public company?
Yes, PolyPid is a public company and is traded under the symbol PYPD
See more information about PolyPid Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.